Intended for healthcare professionals


HPV vaccine cut cervical cancer rates in England by 87%

BMJ 2021; 375 doi: (Published 05 November 2021) Cite this as: BMJ 2021;375:n2689
  1. Ingrid Torjesen
  1. London

The human papillomavirus vaccine has reduced the incidence of cervical cancer by 87% in women in their 20s in England who were offered the vaccine when they were aged 12-13 years as part of the UK HPV vaccination programme, a study published in the Lancet shows.1

Michelle Mitchell, chief executive of the charity Cancer Research UK, hailed the results as a “historic moment” that demonstrated the power of science.

The UK HPV vaccination programme was introduced in 2008, offering vaccines to girls aged 12-13, with a “catch-up” programme of vaccinations offered up to the age of 18.

The Lancet’s population based study used cancer registry data to compare the incidence of cervical cancer and non-invasive cervical carcinoma (CIN3) in seven cohorts of …

View Full Text

Log in

Log in through your institution


* For online subscription